Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kieran H Gallagher

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Topics in Medicinal Chemistry|June 6, 2015
Emerging Nanonisation Technologies: Tailoring Crystalline Versus Amorphous NanomaterialsDolores R Serrano, Kieran H Gallagher, Anne Marie Healy
International Journal of Pharmaceutics|June 27, 2014
Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolationYouness Amharar, Vincent Curtin, Kieran H Gallagher, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 24, 2015
Mitigating unwanted amorphisation: A screening method for the selection of suitable excipientsYouness Amharar, Vincent Curtin, Kieran H Gallagher, et al.
International Journal of Pharmaceutics|September 3, 2013
Reducing mechanical activation-induced amorphisation of salbutamol sulphate by co-processing with selected carboxylic acidsVincent Curtin, Youness Amharar, Kieran H Gallagher, et al.
International Journal of Pharmaceutics|August 13, 2017
Modelling and understanding powder flow properties and compactability of selected active pharmaceutical ingredients, excipients and physical mixtures from critical material propertiesZelalem Ayenew Worku, Dinesh Kumar, João Victor Gomes, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Topics in Medicinal Chemistry|June 6, 2015
Emerging Nanonisation Technologies: Tailoring Crystalline Versus Amorphous NanomaterialsDolores R Serrano, Kieran H Gallagher, Anne Marie Healy
International Journal of Pharmaceutics|June 27, 2014
Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolationYouness Amharar, Vincent Curtin, Kieran H Gallagher, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 24, 2015
Mitigating unwanted amorphisation: A screening method for the selection of suitable excipientsYouness Amharar, Vincent Curtin, Kieran H Gallagher, et al.
International Journal of Pharmaceutics|September 3, 2013
Reducing mechanical activation-induced amorphisation of salbutamol sulphate by co-processing with selected carboxylic acidsVincent Curtin, Youness Amharar, Kieran H Gallagher, et al.
International Journal of Pharmaceutics|August 13, 2017
Modelling and understanding powder flow properties and compactability of selected active pharmaceutical ingredients, excipients and physical mixtures from critical material propertiesZelalem Ayenew Worku, Dinesh Kumar, João Victor Gomes, et al.
Pageof 1